# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BioNTech reports Q1 loss, missing revenue expectations. Despite challenges, BioNTech aims for significant growth, fueled by inn...
U.S. stocks are likely to extend their gains as major index futures are modestly higher on Monday. Strong earnings reports cont...
Planned 2024 Financial Year Expenses and Capex R&D expenses: €2.4B-€2.6B SG&A expenses: €700M-€800M Capital expend...
According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.
Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Sp...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...